Allopurinol cardiovascular data

Researchers at the University of Dundee and colleagues reported data from a double-blind, crossover, U.K. trial in 65 patients with coronary artery disease (CAD) showing that 600 mg/day allopurinol met the primary endpoint of significantly increasing median time to ST depression from baseline vs. placebo at 6 weeks (66 vs. 17 s increase, p=0.0002). ...